T. Rowe Price Associates
OFIX icon

T. Rowe Price Associates’s Orthofix Medical OFIX Stock Holding History

T. Rowe Price Associates’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
104,998
+29,561
+39% +$326K ﹤0.01% 2357
2026
Q1 		$866K Buy
75,437
+12,192
+19% +$161K ﹤0.01% 2227
2025
Q4 		$959K Buy
63,245
+16,556
+35% +$253K ﹤0.01% 2101
2025
Q3 		$684K Buy
46,689
+1,009
+2% +$13.2K ﹤0.01% 2242
2025
Q2 		$510K Buy
45,680
+3,826
+9% +$47.4K ﹤0.01% 2292
2025
Q1 		$683K Buy
41,854
+5,429
+15% +$95.3K ﹤0.01% 2134
2024
Q4 		$636K Buy
36,425
+2,507
+7% +$43.6K ﹤0.01% 2185
2024
Q3 		$530K Buy
33,918
+669
+2% +$10.7K ﹤0.01% 2220
2024
Q2 		$441K Buy
33,249
+292
+0.9% +$4K ﹤0.01% 2241
2024
Q1 		$479K Buy
32,957
+1,236
+4% +$17.1K ﹤0.01% 2229
2023
Q4 		$428K Buy
31,721
+977
+3% +$11.5K ﹤0.01% 2246
2023
Q3 		$396K Sell
30,744
-414
-1% -$7.45K ﹤0.01% 2221
2023
Q2 		$563K Buy
31,158
+459
+1% +$8.57K ﹤0.01% 2073
2023
Q1 		$515K Buy
+30,699
New +$601K ﹤0.01% 2091
2014
Q1 		– Sell
-109,768
Closed -$2.5M – 2512
2013
Q4 		$2.5M Hold
109,768
– – ﹤0.01% 1506
2013
Q3 		$2.29M Sell
109,768
-3,300
-3% -$80.1K ﹤0.01% 1529
2013
Q2 		$3.04M Buy
+113,068
New +$3.39M ﹤0.01% 1476

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

T. Rowe Price Associates's OFIX Position: Q2 2026 in Review

T. Rowe Price Associates increased its Orthofix Medical (OFIX) stake by 39% in Q2 2026, buying an estimated $326K and bringing the position to 104,998 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

T. Rowe Price Associates first reported a position in OFIX in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.04M in Q2 2013. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • T. Rowe Price Associates held 104,998 shares of Orthofix Medical worth $960K as of Q2 2026.
  • T. Rowe Price Associates bought 29,561 Orthofix Medical shares in Q2 2026, an estimated $326K.
  • Orthofix Medical made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2357 holding.
  • T. Rowe Price Associates first reported a position in Orthofix Medical in Q2 2013 and has held it in 17 quarters since.
  • T. Rowe Price Associates's Orthofix Medical position peaked at $3.04M in Q2 2013.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.